Rice Walter Lynn JR sold $206K of UNM

Rice Walter Lynn JR (SVP, Chief Accounting Officer) sold 2,188 shares of Unum Group (UNM) at $94.32 ($0.21M total) on 2026-09-10.

Original reporting
SEC EDGAR · Rice Walter Lynn JR
Published Sep 11, 2026, 9:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UNM
Neutral
medium confidence
Mentioned
$UNM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UNMNeutralLow
01

Why it matters

The transaction is modest and likely reflects personal financial planning rather than a shift in confidence about the company.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming earnings or strategic moves that prompted the insider to liquidate a portion of holdings.

Relevance 4/10Novelty 4/10Timing: filed 2026-09-11

Background

Form 4 filings disclose insider transactions; this filing reports a sale by Unum's Chief Accounting Officer.

Company-level read

Ticker impact

$UNMNeutralMedium confidence
Context

Officer Rice Walter Lynn Jr sold 2,188 shares of Unum Group for $206,361 on 2026-09-10.

Expected impact

Minimal short-term impact; market may view as routine insider sale.

Evidence & confidence

The sale size ($206k) is modest for a mid‑cap insurer and does not signal a material change in ownership.

Market effects

None significant for insurance sector.

No regional effect.

Limited to Unum investors.

Counterpoint

The sale could be a precursor to larger insider activity not yet disclosed.

Key entities

  • Unum Group

    Insurance and employee benefits provider (ticker UNM).

  • Rice Walter Lynn Jr

    Senior Vice President, Chief Accounting Officer at Unum.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UNMMed

Unum Group Stocks Climb 5.19% After JPMorgan Upgrade to Overweight

Unum Group (NYSE:UNM) shares rose 5.19% to $80.74 after JPMorgan upgraded it to Overweight, lowering its price target to $90. The firm cited attractive risk/reward despite lower estimates. Unum reported a Q3 net loss of $2.65 per share due to a $853 million investment loss, but adjusted operating income was $2.20 per share. Core premiums grew 4.7%, while US sales fell 8.5%. The company expects full-year adjusted operating income of $8.30 to $8.50 per share.

$UNMHigh

Unum Group Q3 Earnings Call Highlights

Unum Group (UNM) reported Q3 earnings, noting long-term disability claims 10% above expectations, driven by behavioral health. The company is implementing double-digit rate increases and expects full-year 2026 earnings of $8.30-$8.50 per share. Unum also completed a reinsurance transaction, reducing long-term care exposure by over 40%.

$UNMMedAI 8/10

Unum Group (UNM) (Q3 2026) Earnings Call Highlights: Disability Claims Surge Weighs

Unum Group (UNM) reported Q3 2026 earnings with mixed results. Core premiums grew 5%, and the company returned $1B to shareholders. However, earnings per share of $2.20 missed expectations due to higher disability claims. The group disability benefit ratio rose to 70.6%, and the full-year EPS outlook was revised to $8.30-$8.50. Management attributed the increase in claims to behavioral health issues and expects pricing actions to address the trend.

$UNMHighAI 9/10

Why is Unum stock crashing today?

Unum Group (UNM) stock fell 18.7% to $74.03 after reporting a Q3 2026 GAAP net loss of $419.7M, revenue shortfall of $360M, and adjusted EPS decline of 21%. Barclays cut its price target to $101. The drop is attributed to reinsurance-related charges, rising disability claims, and market focus on earnings deterioration.